Scheduling History: The 1990 Act and the 2004 Prohormone Amendment
How Congress Scheduled Testosterone Over the AMA's Objection, and Then Chased Andro
Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Established and expanded DEA Schedule III control of anabolic steroids
- WADA
- Prohibited (S1 Anabolic Agent)
Reference only. Not medical advice.
What can go wrong
The legal effect is that possession of testosterone or any covered prohormone without a valid prescription is a federal Schedule III offense. The supplement-era lesson is that 'legal prohormone' products repeatedly turned out to be scheduled steroids or undisclosed designer analogues, carrying both legal and health risks.
This is something to take to a clinician. The Atlas can tell you what is known about scheduling history: the 1990 act and the 2004 prohormone amendment in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
This entry focuses on the legislative history and downstream effects of the Anabolic Steroids Control Act of 1990 (Pub. L. 101-647) and the Anabolic Steroid Control Act of 2004 (Pub. L. 108-358), rather than restating their text. The 1990 Act scheduled steroids despite the American Medical Association, FDA, DEA and NIDA testifying that steroids did not meet the Controlled Substances Act's dependence-based criteria, Congress acted on a moral-panic rationale after the 1988 Ben Johnson scandal. The 2004 amendment, prompted by andro/prohormone supplements and the BALCO era, folded precursor compounds into Schedule III.
Congress scheduled testosterone in 1990 even after its own scientific witnesses and the AMA said it did not fit the criteria.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
The CSA schedules drugs by abuse potential and dependence. Anabolic steroids fit awkwardly because they do not produce classic acute intoxication or rapid physical dependence; that is why expert agencies initially resisted scheduling. Congress nonetheless invoked a public-health and youth-protection rationale. The 2004 amendment worked by expanding the statutory definition of 'anabolic steroid' to capture prohormones, precursors that the body converts to active androgens, thereby removing them from the DSHEA supplement category and into controlled status.
The effects the scheduling actually produced
Scheduling did not eliminate non-medical steroid use; epidemiological data show use continued and diversified. Three durable effects followed: (1) every legitimate testosterone prescription became a DEA-regulated, refill-capped transaction, which later made online TRT structurally harder than online ED care; (2) the 2004 prohormone ban triggered the 'designer steroid' response, chemists synthesized analogues not yet listed, the exact dynamic the 2014 DASCA later tried to close; and (3) a robust gray and underground market formed precisely because legal medical access was narrowed to documented deficiency. The scheduling thus shaped the marketplace it was meant to suppress.
Replacement is not the same as a cycle
Scheduling treats replacement and anabolic dosing identically; the law never distinguished a 100 mg/week clinical dose from a prohormone-stacked bodybuilding regimen, leaving the medical/anabolic line to clinical practice rather than statute.
What people get wrong
Often saidExperts agreed steroids belonged in Schedule III
ActuallyMajor scientific and medical bodies, including the AMA, argued they did not meet CSA dependence criteria; Congress scheduled them anyway.
Often saidThe 2004 prohormone ban ended legal steroid precursors
ActuallyIt pushed the market toward unlisted designer analogues, which is why a further 2014 law was needed.
Often saidDHEA was banned in 2004
ActuallyDHEA was explicitly carved out and remains a legal dietary supplement, unlike andro.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- 1990 Act
- Pub. L. 101-647; effective Feb 27, 1991; created Schedule III steroid control
- Notable opposition
- AMA, FDA, DEA and NIDA questioned whether steroids met CSA criteria
- Political trigger
- 1988 Seoul Olympics Ben Johnson stanozolol scandal
- 2004 Act
- Pub. L. 108-358; added prohormones (e.g. androstenedione) and ~26 substances
- 2004 trigger
- Andro supplement boom (McGwire-era) and BALCO/THG revelations
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Scheduling History: The 1990 Act and the 2004 Prohormone Amendment. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Anabolic Steroids Control Act of 19901990
Scheduled steroids over expert-agency objections; effective 1991
Anabolic Steroid Control Act of 20042004
Added androstenedione-type prohormones to Schedule III
Andro / DHEA distinction2004
DHEA was specifically exempted and remained a legal supplement while andro was scheduled